Pulsenmore stands as the global pioneer in home ultrasound technology, revolutionizing the accessibility of ultrasound imaging for remote clinical diagnosis. Our cutting-edge solutions empower individuals to conduct scans from the convenience of home. Our self-scan prenatal home ultrasound enabling expectant mothers to receive timely ultrasound diagnoses from remote healthcare providers. The Pulsenmore prenatal care solution is approved for marketing in Europe, UK, Switzerland, Australia, Brazil and Israel. Pulsenmore is traded on the Tel-Aviv Stock Exchange (TASE: PULS).
$50M sweet spot round size
2014
$50M
from 1 investors over 1 rounds
Pulsenmore raised $50M on June 12, 2022
Investors: GE Healthcare